跳至主要内容
临床试验/NCT03818503
NCT03818503招募中不适用

E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe

European Organisation for Research and Treatment of Cancer - EORTC77 个研究点 分布在 12 个国家目标入组 2,000 人开始时间: 2019年6月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
2,000
试验地点
77
主要终点
Number of patients treated with radiotherapy enrolled in the program

研究概览

简要总结

The primary objective is the collection of real-world data of cancer patients treated with radiotherapy, to support radiotherapy research and to provide evidence of the role of radiation oncology in a multidisciplinary approach. This is an open ended prospective non-interventional non-therapeutic multi-cohort study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pathologically confirmed cancer.
  • Written informed consent for E²-RADIatE according to applicable legal and ethical requirements
  • Planned use of radiotherapy
  • Eligibility of the patient confirmed for at least one cohort confirmed
  • Patients of 12 years and older

排除标准

  • 未提供

结局指标

主要结局

Number of patients treated with radiotherapy enrolled in the program

时间窗: 5 years

次要结局

  • Distant metastasis free survival(5 years)
  • Disease free survival(5 years)
  • Loco-regional control(5 years)
  • Incidence of adverse events related to radiotherapy(5 years)
  • Overall survival(5 years)

研究者

申办方类型
Network
责任方
Sponsor

研究点 (77)

Loading locations...

相似试验

E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure... | 临床试验